Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc. (OCUP) Stock Overview

Explore Ocuphire Pharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

OCUP●NASDAQ
HealthcareBiotechnology
$1.17
$0.16(12.03%)
U.S. Market opens in 15h 20m

Ocuphire Pharma, Inc. (OCUP)

Meyka AI Score

Z

Key Financials

Market Cap31.7M
P/E Ratio-0.89
EPS (TTM)$-0.54
ROE60.69%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

OCUP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Ocuphire Pharma, Inc. (NASDAQ: OCUP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Ocuphire Pharma, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OCUP on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Ocuphire Pharma, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.89 and a market capitalization of 31.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of OCUP on the NASDAQ.

Price Performance (NASDAQ: OCUP)

1-Day Change
N/A
5-Day Change
9.35%
1-Month Change
-12.03%
3-Month Change
-10.00%
6-Month Change
-33.90%
Year-to-Date (YTD) Change
-61.89%
1-Year Change
-58.36%
3-Year Change
-65.59%
5-Year Change
-85.38%
All-Time (Max) Change
-99.92%

Contact Information

https://www.ocuphire.com
248 681 9815
37000 Grand River Avenue, Farmington Hills, MI, 48335

Company Facts

140 Employees
IPO DateNov 10, 2005
CountryUS

Frequently Asked Questions